Shuoteng's February 6th trading volume was $528 million, ranking 279th among U.S. stocks on that day.

2026-03-06 19:12:48

Abstract generation in progress

On February 6, 2026, Zoetis (ZTS) had a trading volume of $528 million, ranking 279th among U.S. stocks for the day. The trading volume decreased by 10.55% compared to yesterday, with a total of 4.1277 million shares traded.

Zoetis (ZTS) rose 0.54% on February 6, 2026, closing at $127.42. The stock has increased by 2.08% over the past 5 trading days, 2.08% for the entire month of February, and 1.27% since the beginning of the year. Over the past 52 weeks, it has decreased by 26.82%.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Zoetis (ZTS)	Trading Volume / USD	Change from Yesterday	Shares Traded
February 6, 2026	$528 million	-10.55%	4.1277 million
February 5, 2026	$590 million	-8.78%	4.6531 million
February 4, 2026	$647 million	+37.27%	5.1062 million
February 3, 2026	$471 million	-7.88%	3.8162 million
February 2, 2026	$511 million	-21.19%	4.1091 million

Zoetis released its Q3 2025 financial report (cumulative) on November 4, 2025. From January 1 to September 30, 2025, revenue was $7.08 billion, a 2.03% increase year-over-year, with a net profit of $2.07 billion, up 8.09% year-over-year.

Zoetis was founded in July 2012 in Delaware, USA. It is a global leader in the animal health industry, focusing on the discovery, development, manufacturing, and commercialization of drugs, vaccines, diagnostic products and services, biological devices, genetic testing, and precision animal health.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes